CD274 and neoplasm: The basic approach of immunotherapy is to evoke an anti-tumor immune response by blocking an immune checkpoint, like programmed death-1/programmed death ligand-1 (PD-1/PD-L1) and cytotoxic T-cell lymphocyte antigen-4, and thereby achieving durable control of a tumor (3).